Target intelligence / Profile preview

Viral protein 1 of picornavirus capsid (VP1)

Target
VP1
Molecular classification
Structural viral protein, Viral capsid component, Other (not a host receptor, enzyme, or transporter)
01

Overview

Viral protein 1 (VP1) is one of four major structural proteins that compose the capsid shell of picornaviruses, a large family of non-enveloped, positive-sense single-stranded RNA viruses. The mature virion contains 60 copies each of four proteins—VP4, VP2, VP3, and VP1, with VP1 forming prominent features on the external surface at five-fold axes known as "canyons", which often serve as sites for cellular receptor binding. The "jelly-roll" β-barrel fold is characteristic for this class. During infection, conformational changes in the capsid—often involving release or rearrangement around VP4/VP1 regions—enable delivery of viral RNA into host cells through membrane penetration mechanisms. The external loops on VP1 are key antigenic determinants targeted by neutralizing antibodies but also display high sequence variability among strains. Some antivirals act by occupying a hydrophobic cavity within VP1 ("pocket factor"), thereby blocking necessary structural transitions during cell entry. Picornaviruses cause diverse human diseases ranging from mild respiratory illness (rhinoviruses) to severe neurological disease (poliovirus), with their pathogenicity closely linked to efficient assembly/disassembly cycles mediated by their structural proteins including VP1.

Other names
VP1Capsid protein VP1Picornavirus capsid protein 1Viral capsid protein 1
02

Mechanism of action

Drugs targeting this molecule typically: - Bind to a hydrophobic pocket within VP1 ("pocket factor"), stabilizing the capsid and preventing conformational changes required for uncoating and genome release into host cells

03

Biological functions

Formation of the viral capsid shellHost cell receptor recognition and bindingFacilitation of viral genome delivery into host cellsImmune evasion (antigenic determinant for neutralizing antibodies)
04

Disease associations

Infection (central to pathogenesis of diseases caused by picornaviruses such as poliovirus, rhinovirus, enteroviruses, hepatitis A virus)
05

Safety considerations

High genetic variability leading to rapid emergence of drug resistance mutations in VP1.Antigenic diversity complicates vaccine design and efficacy across different picornavirus species/strains.No direct safety concerns from targeting this structural viral protein have been highlighted; issues relate more to efficacy/resistance.
06

Interacting drugs

Pleconaril
07

Biomarkers

Antibodies against VP1 are used as biomarkers for infection or immune response monitoring in clinical virology

Beyond the preview

Go deeper on Viral protein 1 of picornavirus capsid (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral protein 1 of picornavirus capsid (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call